Breves Sarah L, Di Giammartino Dafne Campigli, Nicholson James, Cirigliano Stefano, Mahmood Syed Raza, Lee Uk Jin, Martinez-Fundichely Alexander, Jungverdorben Johannes, Singhania Richa, Rajkumar Sandy, Kirou Raphael, Studer Lorenz, Khurana Ekta, Polyzos Alexander, Fine Howard A, Apostolou Effie
Sanford I. Weill Department of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Physiology, Biophysics and Systems Biology Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY, USA; Department of Surgery, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Sanford I. Weill Department of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Mol Cell. 2025 Apr 3;85(7):1330-1348.e6. doi: 10.1016/j.molcel.2025.03.007. Epub 2025 Mar 26.
Dysregulation of enhancer-promoter communication in the three-dimensional (3D) nucleus is increasingly recognized as a potential driver of oncogenic programs. Here, we profiled the 3D enhancer-promoter networks of patient-derived glioblastoma stem cells to identify central regulatory nodes. We focused on hyperconnected 3D hubs and demonstrated that hub-interacting genes exhibit high and coordinated expression at the single-cell level and are associated with oncogenic programs that distinguish glioblastoma from low-grade glioma. Epigenetic silencing of a recurrent hub-with an uncharacterized role in glioblastoma-was sufficient to cause downregulation of hub-connected genes, shifts in transcriptional states, and reduced clonogenicity. Integration of datasets across 16 cancers identified "universal" and cancer-type-specific 3D hubs that enrich for oncogenic programs and factors associated with worse prognosis. Genetic alterations could explain only a small fraction of hub hyperconnectivity and increased activity. Overall, our study provides strong support for the potential central role of 3D regulatory hubs in controlling oncogenic programs and properties.
三维(3D)细胞核中增强子与启动子通讯的失调日益被认为是致癌程序的潜在驱动因素。在此,我们剖析了患者来源的胶质母细胞瘤干细胞的3D增强子-启动子网络,以确定核心调控节点。我们聚焦于高度连接的3D枢纽,并证明与枢纽相互作用的基因在单细胞水平上表现出高表达且协调表达,并且与区分胶质母细胞瘤与低级别胶质瘤的致癌程序相关。一个在胶质母细胞瘤中作用未明的复发性枢纽的表观遗传沉默足以导致枢纽连接基因的下调、转录状态的改变以及克隆形成能力的降低。整合来自16种癌症的数据集,确定了“通用”和癌症类型特异性的3D枢纽,这些枢纽富集了致癌程序以及与预后较差相关的因子。基因改变只能解释一小部分枢纽的高度连接性和活性增加。总体而言,我们的研究为3D调控枢纽在控制致癌程序和特性方面的潜在核心作用提供了有力支持。